Literature DB >> 26169282

The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types.

Brita Singers Sørensen1, Anders Knudsen2, Catja Foged Wittrup1, Steffen Nielsen1, Ninna Aggerholm-Pedersen1, Morten Busk1, Michael Horsman1, Morten Høyer2, Pierre Nourdine Bouchelouche3, Jens Overgaard1, Jan Alsner1.   

Abstract

BACKGROUND AND
PURPOSE: A 15-gene hypoxia profile has previously demonstrated to have both prognostic and predictive impact for hypoxic modification in squamous cell carcinoma of the head and neck. This gene expression profile may also have a prognostic value in other histological cancer types, and could potentially have a function as a universal hypoxia profile. The hypoxia induced upregulation of the included genes, and the validity of the previously used reference genes was established in this study, in a range of different cell lines representing carcinomas of the prostate, colon, and esophagus.
MATERIALS AND METHODS: Eleven adenocarcinoma and one squamous cell lines: Six colon carcinomas (HTC8, HT29, LS174T, SW116, SW948 and T48), 3 prostate carcinomas (LNCaP, DU-145 and PC-3) and 3 esophagus carcinoma cell lines (OE19, OE21 and OE33) were cultured under normoxic or hypoxic conditions (0% O2) for 24hours. Total RNA was extracted and gene expression levels measured by qPCR. For each tissue type, individual reference genes were selected and applied in the normalization of the relative expression levels.
RESULTS: In all three tissue types, individual, optimal, reference genes were selected. In the analysis of the hypoxia induced genes, both the original reference genes and the new selected reference genes were used. There was no significant difference in the obtained data. The gene expression analysis demonstrated cell line specific differences in the hypoxia response of the 15 genes, with BNIP3 not being upregulated at hypoxic conditions in 3 out of 6 colon cancer cell lines, and ALDOA in OE21 and FAM162A and SLC2A1 in SW116 only showing limited hypoxia induction. Furthermore, in the esophagus cell lines, the normoxic and hypoxic expression levels of LOX and BNIP3 were below the detection limit in OE19 and OE33, respectively. However, a combined analysis of the 15 genes in both adenocarcinoma cell lines and squamous carcinoma cell lines demonstrated a very consistent expression pattern in hypoxic induced gene expression across all cell lines.
CONCLUSION: This study addressed the tissue type dependency of hypoxia induced genes included in a 15-gene hypoxic profile in carcinoma cell lines from prostate, colon, and esophagus cancer, and demonstrated that in vitro, with minor fluctuations, the genes in the hypoxic profile are hypoxia inducible, and the hypoxia profile may be applicable in other sites than HNSCC.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal adenocarcinoma; Esophageal carcinoma; Gene expression; Hypoxia; Hypoxia profiles; Prostate adenocarcinoma

Mesh:

Year:  2015        PMID: 26169282     DOI: 10.1016/j.radonc.2015.06.028

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

Review 1.  Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy.

Authors:  Lingjian Yang; Catharine Ml West
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

2.  miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer-Role of PTEN.

Authors:  Aleksandra Majewska; Klaudia Brodaczewska; Aleksandra Filipiak-Duliban; Arkadiusz Kajdasz; Claudine Kieda
Journal:  Biomolecules       Date:  2022-05-11

3.  Association analysis between quantitative MRI features and hypoxia-related genetic profiles in prostate cancer: a pilot study.

Authors:  Yu Sun; Scott Williams; David Byrne; Simon Keam; Hayley M Reynolds; Catherine Mitchell; Darren Wraith; Declan Murphy; Annette Haworth
Journal:  Br J Radiol       Date:  2019-07-30       Impact factor: 3.039

4.  NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.

Authors:  Prashant V Bommi; Vaibhav Chand; Nishit K Mukhopadhyay; Pradip Raychaudhuri; Srilata Bagchi
Journal:  Oncogene       Date:  2019-11-18       Impact factor: 9.867

5.  Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients.

Authors:  Christina S Fjeldbo; Eva-Katrine Aarnes; Eirik Malinen; Gunnar B Kristensen; Heidi Lyng
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

6.  A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma.

Authors:  Ninna Aggerholm-Pedersen; Brita Singers Sørensen; Jens Overgaard; Kasper Toustrup; Steen Baerentzen; Ole Steen Nielsen; Katja Maretty-Kongstad; Marianne Nordsmark; Jan Alsner; Akmal Safwat
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

7.  Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts.

Authors:  Lingjian Yang; Laura Forker; Joely J Irlam; Nischalan Pillay; Ananya Choudhury; Catharine M L West
Journal:  Oncotarget       Date:  2017-12-12

8.  Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma.

Authors:  Yae-Eun Suh; Katherine Lawler; Rhonda Henley-Smith; Lucy Pike; Russell Leek; Sally Barrington; Edward W Odell; Tony Ng; Francesco Pezzella; Teresa Guerrero-Urbano; Mahvash Tavassoli
Journal:  Br J Cancer       Date:  2017-03-21       Impact factor: 7.640

9.  The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.

Authors:  Hoon Kim; Qun Lin; Peter M Glazer; Zhong Yun
Journal:  Breast Cancer Res       Date:  2018-03-06       Impact factor: 6.466

10.  Refinement of an Established Procedure and Its Application for Identification of Hypoxia in Prostate Cancer Xenografts.

Authors:  Pernille B Elming; Thomas R Wittenborn; Morten Busk; Brita S Sørensen; Mathilde Borg Houlberg Thomsen; Trine Strandgaard; Lars Dyrskjøt; Steffen Nielsen; Michael R Horsman
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.